| selenomethionine (SLM) / Holden Comprehensive Cancer Center, The University of Iowa |
NCT00112892: Irinotecan and Selenium in Treating Patients With Advanced Solid Tumors |
|
|
| Completed | 1 | 36 | US | selenium, irinotecan hydrochloride | Roswell Park Cancer Institute | Unspecified Adult Solid Tumor, Protocol Specific | 09/07 | 12/07 | | |
NCT00217516: Selenium in Treating Patients Who Are Undergoing Brachytherapy for Stage I or Stage II Prostate Cancer |
|
|
| Completed | 1 | 18 | US | selenium, placebo | Roswell Park Cancer Institute, National Cancer Institute (NCI) | Prostate Cancer | 02/08 | 10/08 | | |
NCT01497431: Se-Methyl-Seleno-L-Cysteine or Selenomethionine in Preventing Prostate Cancer in Healthy Participants |
|
|
| Completed | 1 | 66 | US | Selenium, Se, Placebo, PLCB, Laboratory Biomarker Analysis, Pharmacological Study, pharmacological studies, Methylselenocysteine, L-Se-Methylselenocysteine, Methylselenocycteine, MSC, Se-Methyl-seleno-L-cysteine, SeMSC | National Cancer Institute (NCI) | No Evidence of Disease, Prostate Carcinoma | 06/14 | 07/14 | | |
| Unknown status | 1 | 50 | US | Selenium, selenomethionine, placebo | University of Illinois at Chicago | Prevention of Colorectal Cancer | 12/14 | 12/16 | | |
| Active, not recruiting | 1 | 56 | RoW | Selenomethionine, L-selenomethionine, Methylselenocysteine, Se-methyl-selenocysteine | University of Auckland, New Zealand, Cancer Trials New Zealand, Counties Manukau Health, Waikato Hospital | Colorectal Adenoma | 06/24 | 08/24 | | |
| Active, not recruiting | 1 | 46 | US | Selenomethionine (SLM), Axitinib | Bilal G. Rahim, Pfizer | Advanced Metastatic Clear Cell Renal Cell Carcinoma (CCRCC) | 08/23 | 05/26 | | |
